Home › Funds › PSP Research LLC › IMNM
PSP Research LLC position in IMNM
IMMUNOME INC · Health Care
PSP Research LLC reported holding 12,000 shares of IMNM (IMMUNOME INC) in its Q3 2026 13F filing — a position valued at US$258K, representing 0.18% of its reported portfolio and ranking #16 among its reported holdings. PSP Research LLC has disclosed IMNM holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR
How PSP Research LLC's IMNM position evolved
PSP Research LLC first disclosed a stake in IMNM in Q4 2025 at 25,245 shares (US$542K). Across 4 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 12,000 shares valued at US$258K — a reduction of -6,000 shares quarter over quarter.. Notable position changes include a 33% trim in Q3 2026 (shares fell 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 25.25K | $542.26K | New |
| Q1 2026 | 20.00K | $437.40K | Reduce |
| Q2 2026 | 18.00K | $381.42K | Reduce |
| Q3 2026 | 12.00K | $258.12K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMNM and 13F data
IMNM (IMMUNOME INC) is a Health Care company. 49 other funds we track also report a position in IMNM — the largest reported positions include Redmile Group, LLC (US$104.1M), Enavate Sciences GP, LLC (US$76.6M), SILVERARC CAPITAL MANAGEMENT, LLC (US$42.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMNM
- Redmile Group, LLC 4.91M sh · $104.08M · Q2 2026
- Enavate Sciences GP, LLC 3.61M sh · $76.58M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 2.02M sh · $42.74M · Q2 2026
- Sofinnova Investments, Inc. 1.72M sh · $36.45M · Q2 2026
- READYSTATE ASSET MANAGEMENT LP 1.61M sh · $34.03M · Q2 2026
- Pivotal bioVenture Partners Investment Advisor LLC 732.51K sh · $15.52M · Q2 2026
- NAN FUNG TRINITY (HK) Ltd 714.55K sh · $15.14M · Q2 2026
- Parkman Healthcare Partners LLC 594.20K sh · $12.59M · Q2 2026
- ALERUS FINANCIAL NA 383.42K sh · $8.12M · Q2 2026
- Atom Investors LP 297.49K sh · $6.30M · Q2 2026
More on PSP Research LLC
FAQ
How long has PSP Research LLC held IMNM?
PSP Research LLC has disclosed IMNM holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is PSP Research LLC's current position in IMNM?
As of Q3 2026, PSP Research LLC holds 12.00K shares of IMNM (IMMUNOME INC), valued at $258.12K, representing 0.18% of its reported portfolio and ranking #16.
Has PSP Research LLC been buying or selling IMNM?
In the latest 13F filing (Q3 2026), PSP Research LLC reduced its position in IMNM.
Which other funds hold IMNM?
Other major institutional holders of IMNM include Redmile Group, LLC, Enavate Sciences GP, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.